138 related articles for article (PubMed ID: 26385494)
1. Review structure- and dynamics-based computational design of anticancer drugs.
Lin JH
Biopolymers; 2016 Jan; 105(1):2-9. PubMed ID: 26385494
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Importance of molecular computer modeling in anticancer drug development.
Geromichalos GD
J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
[TBL] [Abstract][Full Text] [Related]
4. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
5. Identification of type-specific anticancer histone deacetylase inhibitors: road to success.
Noureen N; Rashid H; Kalsoom S
Cancer Chemother Pharmacol; 2010 Sep; 66(4):625-33. PubMed ID: 20401613
[TBL] [Abstract][Full Text] [Related]
6. Structure-based design of molecular cancer therapeutics.
van Montfort RL; Workman P
Trends Biotechnol; 2009 May; 27(5):315-28. PubMed ID: 19339067
[TBL] [Abstract][Full Text] [Related]
7. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
8. [Design of multiple targeted drugs].
Guo YS; Guo ZR
Yao Xue Xue Bao; 2009 Mar; 44(3):276-81. PubMed ID: 19449524
[TBL] [Abstract][Full Text] [Related]
9. Computational approaches for the design of peptides with anti-breast cancer properties.
Shields GC
Future Med Chem; 2009 Apr; 1(1):201-12. PubMed ID: 21426076
[TBL] [Abstract][Full Text] [Related]
10. Targeted drug delivery for breast cancer treatment.
Jin S; Ye K
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):143-53. PubMed ID: 23394116
[TBL] [Abstract][Full Text] [Related]
11. Heat-shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective.
Kumalo HM; Bhakat S; Soliman ME
Chem Biol Drug Des; 2015 Nov; 86(5):1131-60. PubMed ID: 25958815
[TBL] [Abstract][Full Text] [Related]
12. How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs.
Garofalo M; Grazioso G; Cavalli A; Sgrignani J
Molecules; 2020 Apr; 25(7):. PubMed ID: 32290224
[TBL] [Abstract][Full Text] [Related]
13. Novel computational approaches to polypharmacology as a means to define responses to individual drugs.
Xie L; Xie L; Kinnings SL; Bourne PE
Annu Rev Pharmacol Toxicol; 2012; 52():361-79. PubMed ID: 22017683
[TBL] [Abstract][Full Text] [Related]
14. Computational analysis of mTOR signaling pathway: bifurcation, carcinogenesis, and drug discovery.
Wang G; Krueger GR
Anticancer Res; 2010 Jul; 30(7):2683-8. PubMed ID: 20682998
[TBL] [Abstract][Full Text] [Related]
15. Exploring sequence-structure relationships in the tyrosine kinome space: functional classification of the binding specificity mechanisms for cancer therapeutics.
Verkhivker GM
Bioinformatics; 2007 Aug; 23(15):1919-26. PubMed ID: 17537753
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
17. Network pharmacology: the next paradigm in drug discovery.
Hopkins AL
Nat Chem Biol; 2008 Nov; 4(11):682-90. PubMed ID: 18936753
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?
Szumilak M; Wiktorowska-Owczarek A; Stanczak A
Molecules; 2021 Apr; 26(9):. PubMed ID: 33946916
[TBL] [Abstract][Full Text] [Related]
19. Emerging molecular therapies of advanced thyroid cancer.
Catalano MG; Poli R; Pugliese M; Fortunati N; Boccuzzi G
Mol Aspects Med; 2010 Apr; 31(2):215-26. PubMed ID: 20176050
[TBL] [Abstract][Full Text] [Related]
20. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
Chari RV
Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
